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ORIGINAL ARTICLE
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tissues in Zucker fa/fa rats
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Sabine Lehe,f, Gunnar Mellgren g,h and Oddrun A. Gudbrandsen a
aDietary Protein Research Group, Department of Clinical Medicine, University of Bergen, Bergen, Norway; bDepartment of Clinical Science,
University of Bergen, Haukeland University Hospital, Bergen, Norway; cDepartment of Chemistry, University of Bergen, Bergen, Norway;
dNofima BioLab, Bergen, Norway; eDepartment of Pathology, Haukeland University Hospital, Bergen, Norway; fDepartment of Clinical
Medicine, University of Bergen, Bergen, Norway; gDepartment of Clinical Science, KG Jebsen Center for Diabetes Research, University of
Bergen, Haukeland University Hospital, 5021 Bergen, Norway; hHormone Laboratory, Haukeland University Hospital, 5021 Bergen, Norway
ABSTRACT
Knowledge of the health impact of consuming heat-treated versus raw fish fillet is limited. To
investigate effects of baked or raw salmon fillet intake on lipids and n-3 PUFAs in serum and
tissues, obese Zucker fa/fa rats were fed diets containing 25% of protein from baked or raw
salmon fillet and 75% of protein from casein, or casein as the sole protein source (control group)
for four weeks. Salmon diets had similar composition of amino and fatty acids. Growth and
energy intake were similar in all groups. Amounts of lipids and n-3 PUFAs in serum, liver and
skeletal muscle were similar between rats fed baked or raw salmon fillet. When compared to the
control group, rats fed baked salmon had lower serum total and LDL cholesterol and higher
serum triacylglycerol levels. Both raw and baked salmon groups had lower HDL cholesterol level
when compared to control rats. In conclusion, baking as a preparation method does not alter
protein and fat qualities of salmon fillets, and intake of baked and raw salmon fillets gave similar
effects on lipids and n-3 PUFAs in serum and tissues from rats.
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Obesity is a major public health problem. Fish con-
sumption has been associated with cardio protective
properties [1,2], and may therefore be a possible pre-
ventive and therapeutic approach for combating meta-
bolic disturbances such as dyslipidemia, related with
overweight and obesity. Yet, reports on associations of
fish consumption and reduced cardiovascular disease
(CVD) risk are inconsistent [3,4]. Conflicting associa-
tions of fish consumption and risk of CVD have been
suggested to be related to differences in preparation
methods and type of fish consumed in different popula-
tion groups [5,6]. Hitherto, few studies have directly
assessed effects of differently prepared fish fillet on
lipid metabolism and CVD risk factors.
Health benefits of fish consumption have traditionally
been attributed to the long chain n-3 PUFAs eicosapen-
taenoic acid (EPA) and docosahexaenoic acid (DHA),
which are plentiful in fillet from fatty fish [7]. Fish is
also a good source of several different nutrients, includ-
ing high-quality proteins and vitamin D. Fish proteins
are now being recognized for their potential beneficial
effects on lipid metabolism and CVD risk factors [8].
Health effects of fish intake may be affected by pre-
paration methods, as heat treatment can affect nutrient
quality of proteins, fat and micronutrients, the use of fat or
oil during frying may increase the content of unfavourable
fatty acids, and boiling/blanching of fish may lead to loss
of both water-soluble proteins and fat from the fish [9–
11]. Advanced glycated end products (AGEs) are created
in spontaneous reactions, such as between reducing sugars
and free amino groups. AGEs are highly oxidative and
may cause oxidative stress, thus creating an environment
of inflammation [12]. AGEs are present in uncooked
animal-derived foods and additional AGEs are generated
during heat processing. Temperature and duration of
thermal preparation of foods are essential for the amount
of AGEs generated [13,14]. Carboxymethyl-lysine (CML)
and methylglyoxal (MG) are the best characterized AGEs
and are commonly measured when assessing AGEs in diet
and as an indicator of AGE-burden in the body [12–14].
Diets high in AGEs have been reported to increase circu-
lating levels of CML [15].
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Boiling, frying (not deep-frying) and baking/roasting
are the most common preparation methods of fish in
Norway [16]. Baking is a more gentle preparationmethod
than frying and deep-frying, as temperatures are lower,
and additional oils or fats are not needed. Eating raw fish
is becoming increasingly popular in many countries
including Norway, and consumers perceive sushi as a
healthy food choice [17,18]. Still, little is known about
the nutritional value of heat-treated fish versus raw fish in
the human diet, and whether different preparation meth-
ods could affect the health benefits of eating fish.
The Zucker fa/fa rat is a well characterized and
widely used model for human obesity. The rats develop
obesity a few weeks after birth and develop obesity-
related comorbidities such as dyslipidemia and fatty
liver [19]. Previous studies from our lab with diets
containing 25% of protein from fish show that proteins
from different fish species, i.e. cod, herring and salmon,
affect growth, glucose regulation and lipid metabolism
in obese Zucker fa/fa rats [20,21]. In the present study
we investigated the effects of diets containing the same
amount of protein from baked or raw salmon fillet. A
diet with 25% of protein from fish is believed to be
more comparable to the amount of fish protein con-
sumed by humans, in contrast to experimental diets
with 50 or 100% of proteins from fish. Using salmon
fillet as a source of proteins provides a different
approach than consumption of purified hydrolysed
protein or fish oil alone, and might be more transfer-
able to human consumption of fish, as fish is normally
consumed as fillet prepared by different methods and
as part of a varied diet. The aim of the present explora-
tory study was to investigate whether baking of salmon
fillet affected the composition of fatty acids and amino
acids in the fillets, and to compare the effects of baked
and raw salmon on lipids and n-3 PUFAs in serum,
liver, skeletal muscle and epididymal white adipose
tissue (WATepi) in Zucker fa/fa rats.
Materials and methods
Ethical statement
The study protocol was approved by the National
Animal Research Authority of Norway, in accordance
with the Animal Welfare Act and the regulation of
animal experiments (approval no 2014/6979). The
animal care and use programme at the Faculty of
Medicine and Dentistry at University of Bergen is
accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care
International.
Design
Eighteen male Zucker fa/fa rats (HsdHlr:ZUCKER-
Leprfa) obtained from Harlan Laboratories (Indiana,
USA) were randomized into three weight-matched
dietary intervention groups. The rats were housed in
pairs in Makrolon IV cages (EHRET GmbH & Co.),
under standard conditions with a constant humidity of
65 ± 15%, temperature of 20 ± 3⁰C and a light–dark
cycle of 12 hours. Rats were acclimatized under these
conditions for at least one week before the start of the
experiment. Intervention was initiated when rats
weighed 350 ± 20 g. Rats were weighed weekly during
the experimental period. Rats were fed the intervention
diets for four weeks and had ad libitum access to feed
and tap water. Freshly thawed feed was provided daily
in ceramic bowls, and due to powder formula feed the
rats were given wooden chewing sticks. One week
before euthanasia, rats were housed individually for
24 hours on a grid in standard cages to evaluate feed
intake and faeces output.
Diets
Semi-purified diets were prepared according to the
AIN-93G recommendations and contained 20 wt%
proteins (Table 1) [22]. In the salmon diets, baked or
raw salmon fillet constituted 25% of the protein, and
casein was added to provide 75% of the protein.
Casein served as the sole protein source in the con-
trol diet.
Casein was purchased from Sigma-Aldrich (Munich,
Germany). Skin-free salmon fillets from Atlantic
Salmon (farmed Salmo salar, fed 6% EPA+DHA of















Soya oil 70.0 70.0 70.0
Sucrose 90.0 90.0 90.0
Cornstarch 466.0 466.0 512.0
Cellulose 50.0 50.0 50.0
Mineral mix (AIN-93-MX) 35.0 35.0 35.0
Vitamin mix (AIN-93-VX) 10.0 10.0 10.0
L-cysteine 3.0 3.0 3.0
L-methionine 1.6 1.6 1.6
Choline bitartratec 2.5 2.5 2.5




aContains 92.5% crude protein.
bContains 50% crude protein.
cContains 41.1 % choline.
dContains 2.5 g vitamin B12, 2.5 g vitamin K1 and 995 g sucrose per kg.



























fatty acids until 1200 g bodyweight and 4.5% EPA
+DHA in following feeds [23]) were provided by
Leroy Seafood Group (Hordaland, Norway). All other
dietary ingredients were purchased from Dyets Inc.
(Pennsylvania, USA). Baked fish filets were prepared
in oven at 180⁰C for 20 minutes, no oil or fat were
added when baking the fish. Baked and raw salmon
fillets were minced, freeze dried and grinded before
being mixed with the other ingredients in the diets.
Analysis of diets and salmon fillet
The contents of energy, total fat, total amino acids, free
amino acids and taurine in the feeds, as well as vitamin
D3 content of the salmon fillets were analysed by
Nofima, BioLab (Hordaland, Norway). Cholesterol in
the diets was extracted according to the method
described by Bligh and Dyer [24], using a mixture of
methanol and chloroform. The extracted lipid fraction
was evaporated to dryness with nitrogen and re-dis-
solved in isopropanol before cholesterol was analysed
on the Cobas c 111 system (Roche Diagnostics GmbH,
Marburg, Germany) using the CHOL2 (Cholesterol
Gen.2) kit from Roche.
Euthanasia, sampling and measurements
After a 12 h overnight fast with access to water, rats
were anaesthetized with Isoflurane (Isoba vet,
Intervet, Schering-Plough Animal Health, Boxmeer,
the Netherlands) and a mixture of nitrous oxygen
(N2O) and oxygen. Blood was drawn from the heart
and collected in Vacuette Z Serum Clot Activator
Tubes for isolation of serum (Greiner Bio One,
Austria). Liver, thigh skeletal muscle and WATepi
were harvested and weighed. Serum and organs
were immediately frozen in liquid nitrogen and
stored at −80°C until further analyses. The rats
were weighed before fasting. Body length of the rats
was measured with a ruler.
Analyses in serum
Total cholesterol, low density lipoprotein (LDL) cho-
lesterol, high density lipoprotein (HDL) cholesterol,
triacylglycerol (TAG) and total bile acids in fasting
serum samples were analysed at the Laboratory of
Clinical Biochemistry at Haukeland University
Hospital (Bergen, Norway) by accredited methods.
Serum NEFA and free cholesterol were analysed on
the Cobas c 111 system (Roche) using the NEFA FS
kit (DiaSys Diagnostics Systems GmbH, Holzheim,
Germany) and the free cholesterol FS kit (Diagnostic
Systems). The cholesteryl ester concentration was cal-
culated as the difference between total and free choles-
terol. Serum vitamin D was measured by ELISA, using
the 25-OH Vitamin D total (Rat) kit (EIA-5532, from
DRG Instruments GmbH, Germany). Serum CML and
MG concentrations were measured using ELISA-kits
from OxiSelect™ (STA-816 and STA-811, Cell Biolabs
Inc., San Diego, USA).
Analyses of lipids in liver, skeletal muscle and
faeces
Lipids in liver, skeletal muscle and faeces were extracted
according to the method described by Bligh and Dyer
[24], using a mixture of methanol and chloroform. The
extracted lipid fraction was evaporated to dryness with
nitrogen and re-dissolved in isopropanol before TAG
and total cholesterol were analysed on the Cobas c 111
system using the TRIGL (Triglycerides) and CHOL2
(Cholesterol Gen.2) kits from Roche. Liver slices
(approximately 3 mm thick) were fixed in 4% buffered
formaldehyde, processed by standard procedures and
embedded in paraffin. Three micrometer sections were
stained with hematoxylin-eosin. Slides were scanned
with ScanScope® XT (Aperio) at ×40 resulting in a reso-
lution of 0.25 micrometer per pixel. Virtual slides were
viewed in ImageScope 12. Fat storage in liver cells was
quantified by automatic image analysis using the Aperio
deconvolution algorithm. The fat content was calculated
as a percentage of liver by using the total stained area
(mm2) and total analysis area (mm2).
Analyses of bile acids in faeces
Total faecal bile acids (3α-hydroxy bile acids) were mea-
sured in freeze-dried faeces by the method described by
Suckling et al. [25], using Chromabond C18 ec (3 ml/
200 mg, Macherey-Nagel, Düren, Germany) and the
enzymatic bile acid kit from Diazyme Laboratories, Inc.
(California, USA) on the Cobas c111 system.
Analyses of fatty acid composition in diets, serum,
liver, skeletal muscle and white adipose tissue
Lipids were extracted from the different diets, liver and
skeletal muscle as described above. The extracts were
methylated and extracted twice with isooctane as pre-
viously described [26]. Heneicosanoic acid was added
as an internal standard. Serum and WATepi samples
were methylated without prior lipid extraction. Methyl
esters were quantified by an Agilent 7890 gas chroma-
tograph equipped with flame ionization detector and a
BPX-70 capillary column as described in [27]. The fatty



























acid standards were identified by gas chromatography-
mass spectrometry (GC-MS) using the BPX-70 column
and methodology as previously described [28].
Aim and sample size calculation
The aim of this study was to investigate whether baking
of salmon fillet would affect the composition of fatty
acids and amino acids in the fillet when compared to
raw salmon fillet, and to compare the effects of intake
of diets containing baked or raw salmon on lipids and
n-3 PUFAs in serum and tissues in Zucker fa/fa rats.
The sample size calculation for the present study was
conducted using unpublished data from a pilot study
with dietary fish oil in Wistar rats, and the adequate
sample size was calculated to be four–five rats in each
group (depending on the variables analysed) with a
power of 80% and alpha = 0.05.
Statistical analyses
Data were assessed for normal distribution by the
Shapiro-Wilks test and Q-Q plots. Most variables
were normally distributed. All variables were compared
between groups using one-way analysis of variance
(ANOVA) and the Tukey HSD post-hoc test, when
appropriate. Non-normally distributed data were
simultaneously assessed using the non-parametric
Kruskal–Wallis test method; however, findings were
similar and for simplicity only results from ANOVA
testing are presented in the article. The level of statis-
tical significance was set at p < 0.05. Statistical analyses
were performed using IBM SPSS Statistics 23 (IBM
Corporation, New York, USA). Data are presented as
mean with standard deviations. One rat in the control
group had to be euthanized in the first week of the
study due to a serious lesion and poor health and is not
included in the results, therefore n = 5 in the control
group and n = 6 in each of the salmon groups.
Results
Diets
The compositions of the baked and raw salmon diets
were comparable, with similar compositions of amino
acids and fatty acids (Table 2). The energy contents of
salmon diets were comparable with 18.9 kJ/g feed in
the baked salmon diet and 19.1 kJ/g feed in the raw
salmon diet. The control diet had slightly lower energy
content than salmon diets with 18.1 kJ/g feed. Amino
acid composition was generally comparable between
salmon diets and control diet, however taurine was
present only in the salmon diets (Table 2). Contents
of free amino acids in the diets were below limit of
detection except for methionine which was added in its
free form to the diets (data not presented). Ratios of
lysine/arginine and methionine/glycine were margin-
ally lower in both salmon diets compared to the control
diet. The cholesterol content was low in all diets; 0.45,
0.55 and 0.25 µmol cholesterol per gram diet in the
baked salmon, raw salmon and control diet, respec-
tively. The fatty acid compositions of the salmon diets
were markedly different from that of the control diet,
with higher amounts of 16:0, 18:0, 18:1 n-9, 18:1 n-7
and alpha-linolenic acid (ALA, 18:3 n-3) in the former
diets (Table 2). The long chain n-3 PUFAs EPA
(20:5 n-3), docosapentaenoic acid (DPA, 22:5 n-3)
and DHA (22:6 n-3) were present in both salmon
diets, but were not detected in the control diet. Levels
of linoleic acid (18:2 n-6) were comparable between all
three diets. Salmon fillet used in the salmon diets con-
tained 4µg vitamin D3 per 100 g fillet.
Energy intake, growth, body and organ weights
Body weight at baseline, body weight at endpoint,
growth, ratio of weight/square body length, as well as
weights of liver, skeletal muscle (thigh) and WATepi
Table 2. Contents of indispensable amino acids, the functional
amino acid glycine, the conditionally essential amino acid
arginine, taurine, ratios of lysine/arginine and methionine/gly-
cine and fatty acids* in the diets (g/kg diet).
g/kg diet Baked salmon diet Raw salmon diet Control diet
Amino acids
Arginine† 7.9 7.5 6.4
Glycine 5.0 4.8 3.6
Histidine 5.6 5.3 5.1
Isoleucine 10.0 9.4 9.2
Leucine 17.0 17.0 16.0
Lysine 16.0 15.0 14.0
Methionine 7.6 7.1 6.4
Phenylalanine 9.7 9.1 9.1
Threonine 8.0 8.0 7.2
Valine 13.0 12.0 12.0
Taurine 0.1 0.1 ND
Lys/Arg ratio 2.0 2.0 2.2
Met/Gly ratio 1.5 1.5 1.8
Fatty acids
16:0 9.6 9.6 7.5
18:0 3.0 3.0 2.5
18:1 n-9 24.8 26.1 13.9
18:1 n-7 1.6 1.7 0.9
18:2 n-6 34.5 33.9 32.7
18:3 n-3 5.0 5.1 3.9
20:5 n-3 0.5 0.6 ND
22:5 n-3 0.2 0.2 ND
22:6 n-3 1.0 1.1 ND
ND, not detected.
*Only fatty acids found in levels > 0.1 g/kg diet are shown.
†Arginine can be synthesized by the rat, but not in sufficient amounts to
meet the demands for normal growth.



























relative to body weight were similar between baked
salmon, raw salmon and control groups (Table 3).
Energy intake and dry faecal output per kilo body
weight were similar in all three groups.
Serum lipids, bile acids, vitamin D, MG and CML
Serum concentrations of lipids, bile acids, vitamin D,
NEFA, MG and CML were similar between rats fed
baked or raw salmon diets (Table 4). Circulating con-
centrations of NEFA, vitamin D, MG and CML were
also similar between salmon groups and control
group. Serum concentrations of total cholesterol,
HDL cholesterol, LDL cholesterol and bile acids
were significantly lower, and that of TAG was signifi-
cantly higher in the baked salmon group compared to
the control group. In the raw salmon group, the
serum concentration of HDL cholesterol was signifi-
cantly lower, and there were tendencies towards lower
LDL cholesterol and higher TAG in the raw salmon
group compared to control (p values of 0.055 and
0.067, respectively).
Analyses in liver, muscle and faeces
Amounts of total cholesterol and TAG in liver and
muscle, well as daily faecal excretion of cholesterol,
TAG and total bile acids were similar in all groups
(Table 5). Image analysis of the stained liver sections
revealed no differences in percentage of fat between
rats fed baked salmon or raw salmon (p = 0.71,
Figure 1). The liver fat content was significantly
lower in rats fed raw salmon diet (p = 0.038) and
showed a weak tendency to be lower in rats fed
baked salmon (p = 0.15) when compared to the con-
trol group.
Contents of n-3 and n-6 PUFAs in serum, liver,
skeletal muscle and white adipose tissue
The contents of the n-3 PUFAs ALA, EPA, DPA and
DHA in serum, liver and skeletal muscle were similar
between the rats fed baked salmon and raw salmon
(Table 6). Amounts of ALA, DPA and total n-3
PUFA were significantly lower in WATepi from rats
fed baked salmon compared to rats fed raw salmon,
with similar levels of EPA and DHA between the
groups. The contents of n-6 PUFA in serum, liver,
skeletal muscle and WATepi were mostly similar
between the baked salmon and raw salmon groups,
with the exception of higher 18:3n-6 in serum and
lower 18:2n-6 in WATepi from rats fed the baked
salmon diet when compared to rats fed the raw salmon
diet. No differences were seen between the salmon fed
groups for n-3/n-6 PUFA ratio in serum, liver, skeletal
muscle and WATepi.
Contents of ALA, EPA, DPA and DHA and total
amount of n-3 PUFAs were significantly higher in
serum, liver and WATepi from salmon fed rats when
compared to control fed rats. In skeletal muscle, EPA
content was significantly higher in salmon fed rats and
the concentration of ALA was higher in rats fed raw
salmon compared to control. Serum levels of 18:2n-6
and 20:3n-6 were significantly higher, and that of
20:4n-6, 22:4n-6 and 22:5n-6 were significantly lower
in serum from rats fed baked or raw salmon diets when
compared to the control group, with no differences in
serum 18:3n-6 between individual salmon groups and
the control group. Salmon fed rats had significantly
higher levels of 18:2n-6 and 20:3n-6, and significantly
lower level of 22:5n-6 in liver when compared to con-
trols. Salmon fed rats had significantly lower levels of
20:4n-6, 22:4n-6 and 22:5n-6 in skeletal muscle, and
higher 20:3n-6 and lower 22:4n-6 in WATepi. The n-3/
n-6 PUFA ratio was significantly higher in serum, liver,
Table 3. Body weight at baseline, growth and organ weights relative to body weight at time of euthanasia, energy intake and
faecal output one week before euthanasia.
Baked salmon diet Raw salmon diet Control diet ANOVA
Mean SD Mean SD Mean SD P
Body weight at baseline (g) 356 13 356 14 357 14 0.98
Body weight at endpoint (g) 541 23 553 27 570 21 0.17
Growth (%) 52 3 48 12 45 11 0.50
Body weight/square body length (without tail) ratio (kg/m2) 10.1 0.3 9.9 0.4 10.0 0.5 0.78
Liver (g/kg body weight) 36.5 4.8 36.6 3.7 42.9 6.3 0.086
Skeletal muscle (g/kg body weight) 2.9 0.5 3.0 0.5 3.0 0.4 0.83
Epididymal white adipose tissue (g/kg body weight) 31.8 4.6 29.6 4.7 31.3 5.9 0.75
Energy intake (kJ/kg body weight) 1056 142 1194 121 1200 119 0.14
Faecal output (g dry faeces/kg body weight) 3.9 2.0 5.0 1.8 5.9 0.9 0.19
Values are mean and standard deviations, n = 5 in control group, n = 6 in baked salmon group and n = 6 in raw salmon group.
No significant differences were found between groups (p < 0.05; evaluated by one-way ANOVA).



























skeletal muscle and WATepi in rats fed salmon diets
when compared to control rats.
Discussion
Several studies in humans and animals have investi-
gated changes in lipid metabolism after consumption
of fish [29–38]. However, the preparation method is
often not accounted for when interpreting the results.
Differences in preparation methods of fish may explain
some of the different effects on CVD risk factors asso-
ciated with fish intake [5,6]. To the best of our knowl-
edge there are no studies that directly compare the
effects of baked and raw salmon intake on lipids and
n-3 PUFAs in obese rats. More documentation of the
health impact of differently prepared fish is needed,
and the present study provides the first comparisons
of preparation methods and effects on lipids and n-3
PUFA composition in serum and tissues in rats.
In the current study, the baking of salmon did not
affect the fillet content of long chain n-3 PUFAs, total
amino acid composition and the levels of free amino
acids when compared to raw salmon fillet. We
observed no differences between obese Zucker fa/fa
rats fed diets containing baked or raw salmon fillet
regarding growth, energy intake, lipids in serum,
liver, skeletal muscle and faeces, and bile acids in
serum and faeces. Baked and raw salmon intake
affected n-3 PUFA composition in serum, liver and
skeletal muscle of the rats in a similar manner; how-
ever, the contents of total n-3 PUFAs, ALA and DPA in
WATepi were higher in rats fed raw salmon compared
to rats fed baked salmon. Also the total content of n-6
PUFAs and the n-3/n-6 PUFA ratio in serum and
tissues were similar between the salmon groups.
Heat treatment can increase concentrations of AGEs
in fish [14] and therefore raise the AGE-burden after
fish ingestion. Increased AGE-burden may induce oxi-
dative stress, inflammation and, with time, increase the
risk of CVD [12]. Similar serum concentrations of CML
and MG were observed in rats fed baked or raw salmon,
or control diet, suggesting that baking as a preparation
method of fish does not provide enough AGEs to
increase the AGE-burden in rats fed baked salmon
compared to rats fed raw salmon or control diet.
Despite higher energy content in the salmon diets
when compared to the control diet, the energy con-
sumption, growth, ratio of body weight to square body
length and relative organ weights were similar between
all three groups. The salmon diets also contained more
cholesterol compared to the control diet, but still the
HDL cholesterol concentration was lower in both
Table 5. Concentrations of lipids in liver and skeletal muscle









Mean SD Mean SD Mean SD P
Liver
Cholesterol (µmol/g) 7.1 2.3 8.1 1.1 9.3 2.1 0.20
TAG (µmol/g) 125.3 30.3 117.7 39.2 147.1 43.2 0.44
Skeletal muscle
Cholesterol (µmol/g) 1.6 0.1 1.7 0.2 1.6 0.2 0.78
TAG (µmol/g) 17.4 4.5 26.4 15.2 15.7 5.3 0.19
Faeces
Cholesterol(µmol/24 h) 21.0 4.2 23.0 6.8 18.0 5.6 0.37
TAG (µmol/24 h) 2.6 1.3 3.3 2.5 2.3 0.8 0.61
Bile acids (µmol/24 h) 9.1 1.9 10.5 2.3 11.8 2.7 0.20
Values are mean and standard deviations, n = 5 in control group, n = 6 in
baked salmon group, and n = 6 in raw salmon group.
No significant differences were found between groups (p < 0.05; evaluated
by one-way ANOVA).
Table 4. Concentrations of serum lipids, bile acids, vitamin D, MG-BSA and CML-BSA.
Baked salmon diet Raw salmon diet Control diet ANOVA Post hoc test
Mean SD Mean SD Mean SD P P* P‡ P†
Total cholesterol (mmol/l) 4.9 0.8 5.4 0.8 6.3 0.6 0.022 0.53 0.018 0.13
HDL cholesterol (mmol/l) 2.7 0.2 3.3 1.3 5.3 0.3 0.00039 0.50 0.00039 0.003
LDL cholesterol (mmol/l) 0.9 0.3 1.1 0.4 1.5 0.3 0.0080 0.50 0.0067 0.055
Cholesteryl esters (mmol/l) 3.7 0.5 4.3 1.0 4.9 0.5 0.051
TAG (mmol/l) 4.4 1.5 3.9 0.8 2.3 0.5 0.016 0.68 0.015 0.067
NEFA (mmol/l) 0.8 0.1 0.9 0.1 0.9 0.1 0.60
Bile acids (µmol/l) 15.7 7.0 25.5 17.2 46.0 20.9 0.021 0.54 0.018 0.12
Vitamin D (ng/ml) 28.3 5.3 26.2 7.2 27.4 6.7 0.86
MG-BSA1 (µg/ml) 4.9 0.6 5.0 0.7 4.4 1.3 0.56
CML-BSA2 (µg/ml) 2.5 0.7 2.5 0.4 2.7 0.8 0.89
Values are mean and standard deviations, n = 5 in control group, n = 6 in baked salmon group and n = 6 in raw salmon group.
1Methylglyoxal
2Carboxymethyl-lysine
* Baked salmon vs raw salmon.
‡ Baked salmon vs control.
† Raw salmon vs control.
(p < 0.05 were considered significant; evaluated by one-way ANOVA and Tukey HSD post-hoc test).



























baked and raw salmon diet groups compared to the
control group. Intake of baked salmon also resulted in
lower total and LDL cholesterol concentrations, thus
indicating that baked salmon affected circulating lipids
to a greater extent than raw salmon feeding when
compared to control. The observed effects of salmon
diets on HDL cholesterol in the current study may be
mediated by n-3 PUFAs, since fish oil has been shown
to reduce total cholesterol in Zucker rats [39]. Also
taurine, which was only detected in salmon diets, has
been reported to have cholesterol lowering properties
[40], and might explain differences between the salmon
diets and control diet, but as the concentrations of
taurine were similar in salmon diets this cannot explain
why baked salmon seemed to affect circulation choles-
terol to a greater extent than raw salmon. Lower ratios
of lysine/arginine and methionine/glycine [41] in diets
have also been suggested to explain cholesterol-redu-
cing properties of fish protein; however, in the present
study these ratios were similar in all diets. A combina-
tion of fish oil and fish protein from salmon fed to
Wistar rats more efficiently lowered cholesterol con-
centrations than fish oil or fish protein alone [42], and
we should not exclude potential synergistic effects of
protein and fat from the fillets in the present study.
We have recently identified amino acid sequences
with known cholesterol-lowering activity in salmon
[21]. Bioactive peptides in fish can be released from
proteins during digestion and food preparation [43],
and the content of bioactive peptides may therefore be
different in raw and heat treated fish. The more potent
effect of baked salmon when compared to raw salmon
on serum cholesterols in the present study might there-
fore be caused by a higher content of bioactive peptides
with cholesterol-lowering activity in the baked salmon
diet due to the heat treatment of the fillet.
In the present study we observed no difference in
faecal excretion of cholesterol or bile acids between the
groups, indicating that the lower concentrations of
circulating HDL cholesterol in both salmon groups,
and lower serum concentrations of bile acid, total and
LDL cholesterols in the baked salmon group, are not a
result of increased conversion of cholesterol to bile
acids. These findings are in line with previous studies
showing that when Zucker fa/fa rats were fed diets
containing hydrolysed salmon proteins as the sole pro-
tein source, the serum concentrations of total and HDL
cholesterols were lower when compared to a control
group fed a casein-based diet, whereas no differences
were seen in faecal cholesterol and bile acid excretion
between the groups [41,44]. Lower serum bile acid
concentration in rats fed baked salmon could reflect
reduced activity of CYP7A1, catalysing the conversion
of cholesterols to bile acids; however, the hepatic
mRNA expression of CYP7A1 was not affected in
Zucker fa/fa rats fed salmon hydrolysate [41].
Intake of diets containing baked or raw salmon
fillet did not affect hepatic cholesterol levels when
compared to the control diet in the present study.
This is in contrast to a previous study, where we
CBA

















Figure 1. Representative images from liver sections showing steatosis in the groups fed with baked salmon diet (A) and raw salmon
diet (B) compared to steatosis in the control group (C) (stain hematoxylin-eosin, scale bars 100 micrometer). Insets in the upper
right corner display marked-up images for image analysis. The graph shows percentage fat content calculated by image analysis for
individual rats.



























observed larger accumulation of cholesterol in liver
together with lower circulating concentrations of
total and HDL cholesterols when Wistar rats con-
sumed salmon oil and salmon protein hydrolysate in
combination [42]. Diets containing salmon oil and
salmon protein hydrolysate either alone or in combi-
nation did not affect the hepatic HMG-CoA reductase
activity in Wistar rats, suggesting that cholesterol
synthesis in liver was not changed [42]; however,
hepatic HMG-CoA reductase activity was induced
when Zucker fa/fa rats were fed a salmon protein
hydrolysate-containing diet [44]. Others report higher
activity of hepatic microsomal HMG-CoA reductase
in Wistar rats fed EPA ethyl ester and lower activity
of the same enzyme in these rats fed DHA ethyl esters
[45]. Discrepancy between findings in different rat
Table 6. n-3 and n-6 PUFAs in serum, liver, skeletal muscle and epididymal white adipose tissue.
Baked salmon diet Raw salmon diet Control diet ANOVA Post-hoc test
g/100 g fatty acids Mean SD Mean SD Mean SD P P* P‡ P†
Serum
18:3 n-3 (ALA) 0.71 0.17 0.81 0.22 0.36 0.05 0.0021 0.54 0.015 0.0020
20:5 n-3 (EPA) 1.40 0.14 1.35 0.22 0.39 0.10 8.6x10−8 0.86 2.1x10−7 3.8x10−7
22:5 n-3 (DPA) 1.19 0.21 1.19 0.28 0.62 0.07 0.00090 1.00 0.0018 0.0020
22:6 n-3 (DHA) 4.55 0.50 4.80 0.57 2.73 0.13 5.3x10−6 0.61 3.4x10−5 8.0x10−6
n-3 PUFA 7.86 0.84 8.18 1.22 4.11 0.13 4.0x10−6 0.81 1.8x10−5 7.3x10−6
18:2 n-6 12.2 0.96 13.4 1.30 10.6 0.32 0.0012 0.13 0.039 0.00087
18:3n-6 0.33 0.04 0.27 0.03 0.32 0.05 0.048 0.047 0.82 0.17
20:3n-6 1.20 0.12 1.12 0.12 0.76 0.12 9.7x10−5 0.59 0.0010 0.0061
20:4n-6 19.9 3.26 21.1 4.17 31.1 1.84 1.2x10−5 0.80 0.00019 0.00056
22:4n-6 0.37 0.09 0.33 0.07 0.52 0.02 0.0016 0.60 0.010 0.0016
22:5n-6 0.16 0.04 0.15 0.03 0.51 0.04 9.4x10−8 0.96 3.5x10−7 2.6x10−7
n-6 PUFA 34.2 3.3 36.4 3.4 43.8 2.3 0.00039 0.45 3.7x10−5 0.0035
n-3/n-6 PUFA ratio 0.23 0.03 0.23 0.05 0.09 0.01 2.1x10−5 0.98 4.9 x10−5 6.5x10−5
Liver
18:3 n-3 (ALA) 0.76 0.20 0.80 0.17 0.35 0.03 0.00062 0.90 0.0021 0.00093
20:5 n-3 (EPA) 0.33 0.14 0.34 0.10 0.05 0.01 0.00066 0.99 0.0016 0.0013
22:5 n-3 (DPA) 0.49 0.18 0.52 0.14 0.18 0.02 0.0019 0.91 0.0057 0.0027
22:6 n-3 (DHA) 2.25 0.74 2.38 0.79 0.94 0.24 0.0056 0.94 0.014 0.0076
n-3 PUFA 3.83 1.09 4.04 1.07 1.52 0.26 0.00090 0.92 0.0028 0.0014
18:2 n-6 9.24 0.99 9.65 1.31 7.08 0.63 0.0026 0.78 0.011 0.0030
18:3 n-6 0.20 0.02 0.17 0.02 0.19 0.02 0.16
20:3 n-6 0.41 0.11 0.42 0.17 0.17 0.05 0.0077 1.00 0.015 0.013
20:4 n-6 3.84 1.62 3.86 1.54 3.20 0.83 0.69
22:4 n-6 0.12 0.03 0.12 0.04 0.12 0.03 1.00
22:5 n-6 0.06 0.02 0.06 0.03 0.15 0.06 0.0021 1.00 0.0042 0.0042
n-6 PUFA 13.9 1.8 14.3 2.5 10.9 1.0 0.026 0.93 0.058 0.030
n-3/n-6 PUFA ratio 0.27 0.05 0.28 0.03 0.14 0.01 9.9x10−6 0.91 3.7x10−5 2.0x10−5
Skeletal muscle
18:3 n-3 (ALA) 0.92 0.15 1.04 0.24 0.71 0.15 0.028 0.50 0.17 0.023
20:5 n-3 (EPA) 0.28 0.06 0.25 0.06 0.12 0.02 0.00022 0.62 2.5x10−5 0.0013
22:5 n-3 (DPA) 1.80 0.31 1.64 0.58 1.86 0.33 0.69
22:6 n-3 (DHA) 6.16 1.24 5.61 2.26 4.30 0.96 0.19
n-3 PUFA 9.17 1.48 8.55 2.69 6.98 1.17 0.20
18:2 n-6 16.1 1.3 15.4 1.8 16.3 1.9 0.60
20:3 n-6 0.62 0.13 0.53 0.13 0.55 0.10 0.43
20:4 n-6 5.18 0.82 4.20 1.38 7.33 1.49 0.0033 0.39 0.032 0.0027
22:4 n-6 0.34 0.03 0.28 0.07 0.68 0.12 1.7x10−6 0.47 1.3x10−5 2.4x10−6
22:5 n-6 0.29 0.05 0.24 0.08 0.73 0.15 1.3x10−6 0.66 7.4x10−6 2.2x10−6
n-6 PUFA 22.6 2.0 20.7 3.3 25.7 3.6 0.047 0.53 0.24 0.038
n-3/n-6 PUFA ratio 0.40 0.03 0.41 0.07 0.27 0.01 0.00025 1.00 0.00061 0.00056
Adipose tissue
18:3 n-3 (ALA) 1.75 0.09 1.99 0.16 1.50 0.11 5.1x10−5 0.012 0.012 3.4x10−5
20:5 n-3 (EPA) 0.13 0.01 0.15 0.02 0.03 0.003 2.0x10−8 0.20 2.1x10−7 3.5x10−8
22:5 n-3 (DPA) 0.28 0.02 0.32 0.03 0.13 0.01 5.5x10−9 0.027 1.2x10−7 1.2x10−8
22:6 n-3 (DHA) 0.46 0.04 0.51 0.06 0.12 0.01 5.0x10−10 0.062 1.2x10−8 6.7x10−9
n-3 PUFA 2.68 0.15 3.05 0.21 1.81 0.13 3.4x10−8 0.0058 2.0x10−6 3.2x10−8
18:2 n-6 15.9 0.7 17.7 1.6 15.9 1.1 0.030 0.048 1.00 0.058
20:3 n-6 0.20 0.02 0.21 0.02 0.16 0.007 0.00082 0.77 0.0035 0.0010
20:4 n-6 0.38 0.05 0.39 0.04 0.43 0.01 0.083 0.89 0.084 0.18
22:4 n-6 0.11 0.02 0.11 0.02 0.15 0.01 0.0019 1.00 0.0036 0.0039
n-6 PUFA 16.7 0.7 18.5 1.6 16.7 1.1 0.036 0.052 1.00 0.072
n-3/n-6 PUFA ratio 0.16 0.006 0.17 0.01 0.11 0.002 2.4x10−9 0.51 2.1x10−8 1.1x10−8
Values are mean and standard deviations, n = 5 in control group, n = 6 in baked salmon group, and n = 6 in raw salmon group.
* Baked salmon vs raw salmon.
‡ Baked salmon vs control.
† Raw salmon vs control.
(p < 0.05 were considered significant; evaluated by one-way ANOVA and Tukey HSD post-hoc test).



























studies may be caused by dissimilar design, e.g. dif-
ferent rat strain, different doses of protein/fat or dif-
ferent types of fish proteins. Thus, the lower
concentrations of serum total, HDL and LDL choles-
terols in rats fed baked salmon, and the lower HDL
cholesterol in the raw salmon group, may be due to
reduced biosynthesis of cholesterol in rats fed salmon
diets, but other mechanisms responsible for these
findings should not be ruled out.
Reduction in circulating TAG is considered the
most consistent effect of n-3 PUFA consumption
[46]. In the present study, serum TAG were signifi-
cantly higher in rats fed baked salmon (p = 0.015) and
tended to be higher (p = 0.067) in rats fed raw salmon
compared to control fed rats, with no differences in
hepatic TAG levels between the groups. Previously, we
have observed no effects on serum TAG with diets
containing 25% of protein from cod or salmon
[20,21] and higher serum TAG with diet containing
25% of protein from herring [21] in Zucker fa/fa rats.
This indicates that consumption of different types of
fish protein as well as fish fillet may affect serum TAG
in obese rats. Circulating TAG is mainly present in
chylomicrons or VLDL particles and whereas chylomi-
crons are most abundant in the fed state, VLDL parti-
cles are released from liver in the fasting state. Since
serum samples in the current study were obtained after
a 12 h overnight fast, circulating TAG would normally
be packed in VLDL particles, reflecting elevated secre-
tion of TAG from the liver. However, Zucker fa/fa rats
have an attenuated clearance of chylomicrons [47] and
as salmon diets had higher fat content, a 12 h fast
might not be sufficient for clearance of chylomicrons
from the circulation. A slow clearance of chylomicrons
may explain the higher serum TAG in the rats fed
baked salmon when compared to controls.
The histological examination of the hepatic lipid
droplets, mainly consisting of TAG and cholesteryl
esters, suggests that the storage of neutral fat may be
influenced by salmon-containing diets, in particular by
raw salmon intake. We found significantly lower lipid
content in liver from rats fed the raw salmon diet, and
a weak tendency to lower hepatic lipid content in rats
fed baked salmon, when compared to the control
group. The Zucker fa/fa rat develops fatty liver [19],
and a possible beneficial effect of fatty fish intake on
this condition should be explored further.
Suboptimal vitamin D status has been associated
with CVD [48]. The AIN93G diet, which the feed in
the present study is based on, is designed for optimal
animal health and is supplemented with 25 µg vitamin
D3/kg feed. In the present study rats were fed salmon
fillet with low vitamin D3 concentrations providing
only 8 µg additional vitamin D3 per kg feed. Rats fed
diets containing baked or raw salmon had similar
serum concentrations of vitamin D as the control
group, indicating that the additional vitamin D3 pro-
vided by salmon was not sufficient to affect the vitamin
D status further in the present study.
Concentrations of ALA, EPA, DPA, DHA and total
n-3 PUFAs in serum, liver and skeletal muscle were
similar between rats fed baked or raw salmon diets. Rats
fed raw salmon had higher concentrations of ALA, DPA
and total n-3 PUFAs in WATepi compared to rats fed
baked salmon, thus it appears that n-3 fatty acids were
more efficiently incorporated in WATepi when rats were
fed raw salmon as compared to baked salmon. Although
significant, the differences in amount of ALA and DPA in
WATepi are relatively small and the clinical relevance of
this finding is uncertain. Both salmon diets led to higher
total n-3 PUFA content in serum, liver and WATepi
compared to control, and a higher n-3/n-6 PUFA ratio
in serum, liver, skeletal muscle and WATepi, which could
be expected due to the higher n-3 PUFA content of
salmon diets.
The present study provides a comparison of amino
acids and n-3 PUFAs in baked and raw salmon fillets,
and compares the effects of baked and raw salmon
consumption as part of a balanced AIN-93G diet in
rats. To conclude, baking as a preparation method
does not seem to alter the protein and fat qualities
of salmon fillets, and intake of baked and raw salmon
fillets provided similar effects on lipids and n-3 fatty
acid composition in serum and tissues in Zucker fa/fa
rats.
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